Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Zyrtec® (Cetirizine HCl) Syrup vs. Claritin® (Loratadine) Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)

NCT02932774 is registered in ClinicalTrials.gov with Johnson & Johnson Consumer and Personal Products Worldwide as lead sponsor.

NCT NCT02932774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02932774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Zyrtec® (Cetirizine HCl) Syrup vs. Claritin® (Loratadine) Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)
Lead sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2001
Completion date
July 31, 2001
Enrollment
683 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis, hay fever, rhinitis, allergic, seasonal, sar